Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in drug discovery, from novel targets and screening tools through to automation and computational chemistry

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Target Based Discovery

Expanding the Druggable Toolbox: Improving Access to Undruggable Targets

In this Commentary article, we explore the innovative approaches towards drug target identification being championed by Cambridge-based biotechnology company PhoreMost. Identifying new druggable targets may help to address a range of unmet diseases.
Read More
SmartLabs & Automation

Lab Digitalisation: Automation, Transformation, and the Smart Labs of the Future

The quality control labs of the future have been envisioned as fully-integrated environments, automated through the capture of data in real-time. By developing labs with digital output in mind, researchers at all scales can plan for the future and refine their approach to lab digitalisation.
Read More
Medicinal Chemistry & Drug Design

Mcule: Compound Sourcing Expert

Mcule is a leading chemical marketplace for drug discovery where you can order small-molecule samples from a high-quality database. We acquire the compounds from the manufacturers and deliver them in a consolidated package, in the format specified by you
Read More
Target Based Discovery

Protein Linked to Increased Lung Cancer Survival

Evidence shows that targeting TLR2 with an agonist reduces lung tumour growth in mouse models.
Read More
AI, Machine Learning & Computational Drug Design

Cortical Labs Secures $10M to Revolutionise AI with Biological Neurons

AI startup raises funds to advance commercialisation of groundbreaking biological intelligence operating system.
Read More
AI, Machine Learning & Computational Drug Design

$1.2m Quantum Computing Drug Discovery Grant Secured by Penn State Researchers

The grant will help researchers tackle diseases like cancer using quantum computing drug discovery
Read More
AI, Machine Learning & Computational Drug Design

AI/ML Approaches in Drug Development: Applied Machine Learning in Clinical Trials

The focus in the pharmaceutical industry has been, and will remain, on generating cheaper and more detailed data through the applications of AI/ML techniques which can be interpreted more easily.
Read More
AI, Machine Learning & Computational Drug Design

Alphabet’s Calico and Terray Tx Announce Partnership to Tackle Age Related Disease

A partnership between computational drug discovery company Terray and Alphabet's Calico will focus on new therapies to fight age related disease.
Read More
AI, Machine Learning & Computational Drug Design

Orion Granted €10m to Build AI-Based ‘Research Ecosystem’ in Finland

A Finnish government agency has awarded the pharma company €?10 million to invest in their research ecosystem utilising AI and data science.
Read More
Pharma Data

Biobank Frameworks: Utilising Federated Machine Learning to Augment Data Solutions

Data quality, bias, and standardisation are all important to account for when planning for federated and non-federated learning factoring in recurrent neural networks. Biobank frameworks offer the opportunity to augment healthcare data through the appropriate implementation of machine learning.
Read More
Pharma Data

Real-World Data in Real-World Applications: Informing Future Approaches to Healthcare Provision and Drug Development

If some gaps in patient data are inevitable, then the use of RWE and RWD presents an opportunity to fill them in synthetically. Coordinated data sharing is an important aspect of consistent RWD usage.
Read More
Medicinal Chemistry & Drug Design

Bicycle Therapeutics Publishes Preclinical Data from Nectin-4 Targeting Cancer Drug

A paper published in the Journal of Medicinal Chemistry highlights Cambridge, UK based biotech, Bicycle Therapeutics’ findings regarding bicycle toxin conjugate, BT8009.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery